Perampanel (Fycompa®) is indicated for the treatment of partial-onset seizures (POS) with or without secondarily generalised seizures in patients from 4 years of age and older.
Perampanel (Fycompa®) is indicated for the adjunctive treatment of primary generalised tonic-clonic seizures (PGTCS) in patients from 7 years of age and older with idiopathic generalised epilepsy (IGE).